BHS Webinars
Optimize treatment selection and sequencing for R/R MM patients
This BHS Webinar is on "Optimize treatment selection and sequencing for R/R MM patients"
Language: English
Supported by AMGEN
Driving your CAR-T to the right patients: beyond DLBCL NOS?
This BHS Webinar is on "Driving your CAR-T to the right patients: beyond DLBCL NOS?"
Language: English
Supported by GILEAD
CLL: What have we learned now and what will the future bring?
This BHS Webinar is on "CLL: What have we learned now and what will the future bring?"
Language: English
Supported by Janssen
AML in Belgium: an Update
This BHS Webinar is on "AML in Belgium: an Update".
Language: English
Supported by Pfizer
Coping project: U hebt een chronische ziekte. En nu… ? / Vous avez une maladie chronique. Et maintenant...?
This BHS Webinar is on "Coping project: U hebt een chronische ziekte. En nu… ? / Vous avez une maladie chronique. Et Maintenant.. ".
Language: English & (Dutch & French)
Supported by Sanofi
Vaccine-induced thrombotic thrombocytopenia (VITT)
This BHS Webinar, on Vaccine-induced thrombotic thrombocytopenia (VITT).
Language: English
Supported by Sobi
Bone health: revalidation of patients with hematological malignancies
This BHS Webinar is on: Bone health: revalidation of patients with hematological malignancies
Language: Dutch & French
Supported by Amgen
What you need to know about CTCL and PTCL?
This BHS Webinar is on "What you need to know about CTCL and PTCL".
Language: English
Supported by Takeda
How to manage adult ITP in 2021 in Belgium?
This webinar highlights how Primary Immune Thrombocytopenia can be managed in adults in 2021.
Language: English
Sponsored by Novartis
COVID-19 in Belgian Hematology Patients
The webinar analyses the impact of COVID-19 on hematology patients in Belgium.
Language: French and Dutch
Sponsored by Janssen